<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yanagita E</submitter><funding>Research Grant of the Princess Takamatsu Cancer Research Fund</funding><funding>Japan Agency for Medical Research and Development</funding><pagination>198-206</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11551815</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>73(5)</volume><pubmed_abstract>The acquisition of high-quality biospecimens and the appropriate handling of these materials are indispensable for successful clinical sequencing. We developed a cancer clinical sequencing system targeting 160 cancer genes: PleSSision-Rapid. Through the PleSSision-Rapid system, we have analyzed DNA quality evaluated by DIN (DNA integrity number) with 1329 formalin-fixed paraffin embedded (FFPE) samples including 477 prospectively collected tissues for genomic test (P) and 852 archival samples after routine pathological diagnosis (A1/A2). As a result, the samples with more than DIN 2.1 was 92.0% (439/477) in prospectively collected sample (P), while it was 85.6% (332/388) and 76.7% (356/464) in two types of archival samples (A1/A2). We performed the PleSSision-Rapid sequence using the sampl</pubmed_abstract><journal>Pathology international</journal><pubmed_title>The DNA integrity number and concentration are useful parameters for successful comprehensive genomic profiling test for cancer using formalin-fixed paraffin embedded tissue.</pubmed_title><pmcid>PMC11551815</pmcid><funding_grant_id>21ck0106448S0404</funding_grant_id><pubmed_authors>Nishihara H</pubmed_authors><pubmed_authors>Nakamura K</pubmed_authors><pubmed_authors>Kobayashi T</pubmed_authors><pubmed_authors>Yanagita E</pubmed_authors><pubmed_authors>Yamada H</pubmed_authors><pubmed_authors>Aimono E</pubmed_authors><pubmed_authors>Hirasawa A</pubmed_authors></additional><is_claimable>false</is_claimable><name>The DNA integrity number and concentration are useful parameters for successful comprehensive genomic profiling test for cancer using formalin-fixed paraffin embedded tissue.</name><description>The acquisition of high-quality biospecimens and the appropriate handling of these materials are indispensable for successful clinical sequencing. We developed a cancer clinical sequencing system targeting 160 cancer genes: PleSSision-Rapid. Through the PleSSision-Rapid system, we have analyzed DNA quality evaluated by DIN (DNA integrity number) with 1329 formalin-fixed paraffin embedded (FFPE) samples including 477 prospectively collected tissues for genomic test (P) and 852 archival samples after routine pathological diagnosis (A1/A2). As a result, the samples with more than DIN 2.1 was 92.0% (439/477) in prospectively collected sample (P), while it was 85.6% (332/388) and 76.7% (356/464) in two types of archival samples (A1/A2). We performed the PleSSision-Rapid sequence using the sampl</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 May</publication><modification>2026-07-11T03:18:14.55Z</modification><creation>2025-04-04T02:54:02.565Z</creation></dates><accession>S-EPMC11551815</accession><cross_references><pubmed>36971494</pubmed><doi>10.1111/pin.13318</doi></cross_references></HashMap>